Although many physicians and patients would like to see prior authorization disappear entirely from the care planning process (along with other utilization management measures), it’s a necessary tool for curbing unnecessary spending. However, the current approach to prior authorization is broken and needs to change.

Now Available For Download

Reimagining Prior Authorization for Musculoskeletal Care

Summary of Reimagining Prior Authorization White Paper:

Current approaches to utilization management (UM) and prior authorization (PA) are broken and create issues for patients, physicians, and payers alike. Our vision for the next generation of PA will ultimately help physicians deliver proper care without delay and across every aspect of a patient’s journey. To realize this vision, Cohere Health and the American Academy of Orthopaedic Surgeons (AAOS) have joined forces to reimagine PA for musculoskeletal care at a national scale.

In our latest white paper, we discuss how combining our technology and AAOS’s clinical expertise has transformed a historically burdensome process into a strategic asset for health plans that enables better patient outcomes without delays.

About the AAOS

With more than 39,000 members, the American Academy of Orthopaedic Surgeons (AAOS) is the world’s largest medical association of musculoskeletal specialists. The AAOS is the trusted leader in advancing musculoskeletal health. It provides the highest quality, most comprehensive education to help orthopaedic surgeons and allied health professionals at every career level to best treat patients in their daily practices. The AAOS is the source for information on bone and joint conditions, treatments, and related musculoskeletal health care issues, and it leads the health care discussion on advancing quality.

About Cohere Health
Cohere drives collaborative utilization management (UM) by aligning physicians and health plans on evidence-based care paths for the patient’s entire care journey. By integrating these care paths into the prior authorization submission process, Cohere’s digital UM platform reduces denial rates and medical expenses while improving patient outcomes. The company is a winner of the TripleTree iAward and has been named to both Fierce Healthcare’s “Fierce 15” and CB Insights’ Digital Health 150 lists. Cohere’s investors include Flare Capital Partners, Define Ventures, Deerfield, Polaris Partners, and Longitude Capital.